Exelixis - M&A Summary and Business Overview

Life ScienceCompany

Exelixis M&A Summary

Exelixis has acquired 3 companies, including 1 in the last 5 years.

Exelixis’ largest acquisition to date was in 2021, when it acquired GamaMabs Pharma - AMHR2 Antibody Technology for $5M. Exelixis has acquired in 2 different US states, and 2 countries. The Company’s most targeted sectors include life science (100%).

Exelixis Business Overview

Where is Exelixis headquartered?

Exelixis is headquartered in Alameda, California.

What is Exelixis’ revenue?

Exelixis disclosed revenue of 1,830M USD for 2023 and 1,611M USD for 2022.

How many employees does Exelixis have?

Exelixis has 1,310 employees.

What sector is Exelixis in?

Exelixis is a life science company.

When was Exelixis founded?

Exelixis was founded in 1994.

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity3
  • Total Sectors Invested 1
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 1

Exelixis

Exelixis, Inc.

1851 Harbor Bay Parkway,
Alameda, California 94502
United States,
(650) 837-7000
www.exelixis.com

Exelixis is a biopharmaceutical company focused on developing and commercializing small molecule therapies with the potential to improve the treatment of cancer. Exelixis was founded in 1994 and is based in Alameda, California.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.2/yr) # 2 - 1 - - - 3
vol $5M $5M
Sell (0.0/yr) # - - - - - - 0
  3

Most Recent M&A

Company Date Value Type
GamaMabs Pharma - AMHR2 Antibody Technology 2021-05-04 5M USD Divestiture
Toulouse, France
X-Ceptor Therapeutics, Inc. 2005-01-14 - Add-on Acquisition
San Diego, California
Agritope, Inc. 2000-08-01 - Add-on Acquisition
Portland, Oregon
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 3 (100%) 5M (100%) - -
Total 3 $5M - -

By Geo

State/Country Buy Value Sell Value
United States 2 - - -
  Oregon 1 - - -
  California 1 - - -
France 1 5M - -
Domestic 2 (67%) - - -
Cross-border 1 (33%) 5M (100%) - -
Total 3 $5M - -

Deal Values

buy # Total
< $100M 1 $5M
TOTAL $5M
Largest GamaMabs Pharma - AMHR2 Antibody Technology
$5M (2021-05-04)

M&A Connections

Deals
Acquired from
Strategic(s)
33%
1 (33%)

 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.